Showing results (171-180 of 202) with videos related to
Sort By:
Pageof 21
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitorsJohn L Musachio, Jinsoo Hong, Masanori Ichise, et al.The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaineAlan P Kozikowski, Kenneth M Johnson, Olivier Deschaux, et al.The Journal of Pharmacology and Experimental Therapeutics|September 25, 2010
The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization propertiesBarbara J Caldarone, Neil E Paterson, Jia Zhou, et al.International Microbiology : the Official Journal of the Spanish Society for Microbiology|June 21, 2019
The preclinical candidate indole-2-carboxamide improves immune responses to Mycobacterium tuberculosis infection in healthy subjects and individuals with type 2 diabetesRuoqiong Cao, Hicret Islamoglu, Garrett Teskey, et al.Journal of Medicinal Chemistry|December 26, 2015
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition ModelsJianjun Cheng, Patrick M Giguere, Claire M Schmerberg, et al.Bioorganic & Medicinal Chemistry Letters|November 18, 2008
Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitorsSrinivas Reddy Chirapu, Boobalan Pachaiyappan, Hikmet F Nural, et al.Psychopharmacology|April 14, 2011
Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380Barbara J Caldarone, Daguang Wang, Neil E Paterson, et al.Cancer Research|April 17, 2004
Preferential inhibition of Akt and killing of Akt-dependent cancer cells by rationally designed phosphatidylinositol ether lipid analoguesS Sianna Castillo, John Brognard, Pavel A Petukhov, et al.Structure (London, England : 1993)|February 14, 2004
Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1David Komander, Gursant S Kular, Alexander W Schüttelkopf, et al.Molecular Cancer Therapeutics|February 17, 2005
Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survivalRubén W Carón, Adly Yacoub, Min Li, et al.Pageof 21